...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Apabetalone

"The investigators plan to measure AD biomarkers in plasma samples from the study, to learn if a benefit occurred in AD or vascular dementia, or both (Dec 2019 conference news)."

 

Was it already known that they were planning to do this?

Share
New Message
Please login to post a reply